A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00254254
Recruitment Status : Completed
First Posted : November 16, 2005
Last Update Posted : February 23, 2015
Eli Lilly and Company
Information provided by (Responsible Party):